Original Research
Published on 26 Feb 2021
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2021.637420
- 10,701 views
- 49 citations


